Search Results - Stuopelytė, K.

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Down-regulation of miR-149 in TMPRSS2-ERG gene fusion-positive prostate cancer

    Down-regulation of miR-149 in TMPRSS2-ERG gene fusion-positive prostate cancer by Sabaliauskaitė, R, Stuopelytė, K, Visakorpi, T, Jankevičius, F, Jarmalaitė, S

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    44 - Down-regulation of miR-149 in TMPRSS2-ERG gene fusion-positive prostate cancer

    44 - Down-regulation of miR-149 in TMPRSS2-ERG gene fusion-positive prostate cancer by Sabaliauskaitė, R., Stuopelytė, K., Visakorpi, T., Jankevičius, F., Jarmalaitė, S.

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    51 - Blood-circulating androgen receptor variants as markers for progression and response to treatment in prostate cancer patients

    51 - Blood-circulating androgen receptor variants as markers for progression and response to treatment in prostate cancer patients by Stuopelyte, K., Sestokaite, A., Haflidadottir, B.S., Visakorpi, T., Ulys, A., Jankevicius, F., Jarmalaite, S.

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Blood-circulating androgen receptor variants as markers for progression and response to treatment in prostate cancer patients

    Blood-circulating androgen receptor variants as markers for progression and response to treatment in prostate cancer patients by Stuopelyte, K., Sestokaite, A., Haflidadottir, B.S., Visakorpi, T., Ulys, A., Jankevicius, F., Jarmalaite, S.

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Analysis of AR-FL and AR-V1 in whole blood of patients with castration resistant prostate cancer as a tool for predicting response to abiraterone acetate

    Analysis of AR-FL and AR-V1 in whole blood of patients with castration resistant prostate cancer as a tool for predicting response to abiraterone acetate by Stuopelyte, K., Sabaliauskaite, R., Bakavicius, A., Hafliidadóttir, B.S., Visakorpi, T., Väänänen, R.M., Patel, C., Danila, D.C., Lilja, H., Lazutka, J.R., Ulys, A., Jankevicius, F., Jarmalaite, S.

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    P42 - Analysis of AR-FL and AR-V1 in whole blood of patients with castration resistant prostate cancer as a tool for predicting response to abiraterone acetate

    P42 - Analysis of AR-FL and AR-V1 in whole blood of patients with castration resistant prostate cancer as a tool for predicting response to abiraterone acetate by Stuopelyte, K., Sabaliauskaite, R., Bakavicius, A., Hafliidadóttir, B.S., Visakorpi, T., Väänänen, R.M., Patel, C., Danila, D.C., Lilja, H., Lazutka, J.R., Ulys, A., Jankevicius, F., Jarmalaite, S.

    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Predicting abiraterone acetate treatment resistance from blood-circulating androgen receptor variants in castration-resistant prostate cancer

    Predicting abiraterone acetate treatment resistance from blood-circulating androgen receptor variants in castration-resistant prostate cancer by Stuopelyte, K., Bakavicius, A., Sabaliauskaite, R., Haflidadóttir, B.S., Visakorpi, T., Väänänen, R.M., Patel, C., Danila, D.C., Lilja, H., Lazutka, J.R., Ulys, A., Jankevicius, F., Jarmalaite, S.

    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    4 - Predicting abiraterone acetate treatment resistance from blood-circulating androgen receptor variants in castration-resistant prostate cancer

    4 - Predicting abiraterone acetate treatment resistance from blood-circulating androgen receptor variants in castration-resistant prostate cancer by Stuopelyte, K., Bakavicius, A., Sabaliauskaite, R., Haflidadóttir, B.S., Visakorpi, T., Väänänen, R.M., Patel, C., Danila, D.C., Lilja, H., Lazutka, J.R., Ulys, A., Jankevicius, F., Jarmalaite, S.

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: